Agriflu Market Outlook Highlights The Next Major Growth Opportunities
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Agriflu Market Revenue Growth Supported By A CAGR Of % Through 2030
The expansion observed during the historical timeframe was driven by a combination of recurrent influenza epidemics, widespread public vaccination drives, initiatives aimed at boosting healthcare awareness, hospital-administered immunization efforts, and the granting of regulatory approvals for influenza vaccines.
Growth during the forecast period is driven by an aging population, broader national vaccination schedules, increased healthcare expenditure, innovations in vaccine development, and stronger pandemic readiness measures. Key trends shaping this period encompass growing demand for seasonal flu shots, wider use of quadrivalent vaccines, a stronger emphasis on preventive care, the expansion of government-led immunization initiatives, and enhancements in cold chain logistics for vaccine distribution.
Download A Free Sample Report For Comprehensive Market Insights:
Agriflu Market Demand Drivers Creating New Revenue Opportunities
The growing number of influenza cases is set to drive the agriflu market forward. Influenza, often referred to as the flu, is a contagious respiratory illness caused by influenza viruses. The rise in flu cases is linked to factors like increased global travel, the virus mutating into new strains, seasonal changes, limited population immunity, and inadequate vaccination coverage in some areas. Agriflu offers targeted vaccination for poultry, helping to control the spread of avian influenza and lowering the chance of viral transmission between birds and humans. This makes it a key tool in managing outbreaks and preventing potential public health threats. For example, in October 2023, the World Health Organization, based in Switzerland, reported around a billion cases of seasonal influenza each year, with 3 to 5 million of those leading to severe illness. As a result, the rising number of influenza cases is boosting the agriflu market.
Government-led healthcare research and development initiatives are expected to drive growth in the agriflu market. These initiatives include specific actions, programs, policies, or projects carried out by government authorities at local, regional, national, or international levels to tackle particular issues, achieve certain goals, or bring about positive societal changes. A number of government bodies are launching various healthcare programs to support areas including agriflu. For instance, in May 2024, the Office for National Statistics, a UK government department, noted that total healthcare expenditure grew by 5.6% in nominal terms from 2022 to 2023, marking a significant increase compared to the 0.9% growth seen in 2022. Consequently, the expansion of government initiatives for healthcare research and development is fueling the agriflu market.
The rise in immunization programs is expected to accelerate the growth of the agriflu market. These programs are structured public health efforts designed to protect individuals and communities from infectious diseases through vaccine administration. Their increase is driven by a growing acknowledgment of their effectiveness in stopping the spread of infectious diseases, expanded global vaccination coverage, advances in vaccine technology, heightened awareness of public health risks, and a push to better protect vulnerable groups like infants, the elderly, and those with weakened immune systems. Immunization programs provide targeted vaccines, such as agriflu for poultry, which helps control avian influenza spread, lowers the risk of zoonotic transmission to humans, and supports wider public health efforts to prevent flu outbreaks, safeguarding both animal and human populations from the virus’s harmful effects. For example, in January 2024, the National Health Service, a UK government agency, launched a vaccine strategy with immunization goals that includes community-based vaccination services focused on underserved and marginalized groups, using multidisciplinary teams to improve access and outreach. Therefore, the expansion of immunization programs is driving the agriflu market.
Agriflu Market Segment Landscape And Growth Potential
The agriflu market covered in this report is segmented –
1) By Clinical Indication: Avian Influenza (Bird Flu), Foot and Mouth Disease (FMD), Classical Swine Fever (CSF), Other Indications
2) By Route Of Administration: Injectable Vaccines, Nasal Spray Vaccines
3) By Distribution Channel: Hospitals And Clinics, Retail And Specialty Pharmacies, Government And Institutional Supply
Agriflu Market Competitive Landscape: Who Are The Leading Companies?
Major companies operating in the agriflu market are Sanofi Pasteur S.A.
Access The Complete Agriflu Market Report:
Agriflu Market Regional Distribution: Which Areas Drive Market Expansion?
North America was the largest region in the agriflu market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the agriflu market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
